References
- Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR. Am. J. Roentgenol. 149(2), 357–363 (1987).
- Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J. Neurochem. 120(1), 7–25 (2012).
- Khalil M, Langkammer C, Ropele S et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 77(18), 1691–1697 (2011).
- Ceccarelli A, Rocca MA, Neema M et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult. Scler. 16(1), 39–44 (2010).
- Hagemeier J, Weinstock-Guttman B, Bergsland N et al. Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR. Am. J. Neuroradiol. 33(8), 1596–1601 (2012).
- Al-Radaideh AM, Wharton SJ, Lim SY et al. Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome. Mult. Scler. doi:10.1177/1352458512465135 (2012) (Epub ahead of print).
- Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch. Pathol. Lab. Med. 106(8), 397–399 (1982).
- Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 51(2), 260–265 (1988).
- Campbell GR, Mahad DJ. Mitochondrial changes associated with demyelination: consequences for axonal integrity. Mitochondrion 12(2), 173–179 (2012).
- Levi S, Rovida E. The role of iron in mitochondrial function. Biochim. Biophys. Acta 1790(7), 629–636 (2009).
- Horowitz MP, Greenamyre JT. Mitochondrial iron metabolism and its role in neurodegeneration. J. Alzheimers Dis. 20(Suppl. 2), S551–S568 (2010).
- LeVine SM. Iron deposits in multiple sclerosis and Alzheimer’s disease brains. Brain Res. 760(1–2), 298–303 (1997).
- Williams R, Rohr AM, Wang WT et al. Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci. 12, 59 (2011).
- Hagemeier J, Yeh EA, Brown MH et al. Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Mult. Scler. doi:10.1177/1352458512459289 (2012) (Epub ahead of print).
- Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52(3), 612–618 (2004).
- Yao B, Li TQ, van Gelderen P, Shmueli K, de Zwart JA, Duyn JH. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 44(4), 1259–1266 (2009).
- Haacke EM, Makki M, Ge Y et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J. Magn. Reson. Imaging 29(3), 537–544 (2009).
- Onyszchuk G, LeVine SM, Brooks WM, Berman NE. Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci. Lett. 452(2), 204–208 (2009).
- Koike T, Yang Y, Suzuki K, Zheng X. Axon and dendrite degeneration: its mechanisms and protective experimental paradigms. Neurochem. Int. 52(4–5), 751–760 (2008).
- Ceccarelli A, Filippi M, Neema M et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult. Scler. 15(6), 678–686 (2009).